Amicus Therapeutics (NASDAQ: FOLD) and Scioderm, Inc. a privately-held biopharmaceutical company focused on developing innovative therapies for treating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Imperial Capital Cuts Price Target on Quanex (NX) Following Announced Woodcraft Industries Acquisition September 1, 2015 7:21 AM Cowen Raises Price Target on Amicus Therapeutics (FOLD) Following Announced Deal for Scioderm September 1, 2015 7:10 AM Cowen Remains Bullish on Cowen ITT Corp. (ITT) as the Company Supplements High-Performance Auto Business September 1, 2015 7:00 AM Leerink Partners Remains Bullish on Amicus Therapeutics (FOLD) Following Announced Scioderm Acquisition August 31, 2015 2:00 PM